Denmark urges EU to tighten Russian visa restrictions after alleged assassination plot
Denmark has urged European Union countries to introduce tougher travel restrictions on Russian nationals following allegations that Moscow's in...
Israeli and British scientists have developed a breakthrough blood test capable of detecting Parkinson’s disease in its earliest stages—before symptoms even begin—potentially revolutionizing diagnosis and treatment.
A joint team of researchers from Israel and the UK has unveiled a fast, affordable, and highly accurate blood test that can identify Parkinson’s disease long before clinical symptoms arise, The Press Service of Israel (TPS-IL) reports.
Parkinson’s, a progressive neurodegenerative disorder, affects over 10 million people globally and is notoriously difficult to diagnose early. By the time symptoms like tremors or stiffness appear, significant and often irreversible neurological damage has usually occurred.
The new test, based on qPCR technology, detects subtle changes in RNA fragments—specifically RGTTCRA-tRF—that are linked to the early development of the disease. This allows for pre-symptomatic diagnosis, enabling earlier interventions that could delay or even prevent disease progression.
The study was led by PhD student Nimrod Madrer and supervised by Prof. Hermona Soreq at the Hebrew University of Jerusalem, in collaboration with Dr. Iddo Paldor of the Shaare Zedek Medical Center and Dr. Eyal Soreq of the University of Surrey and Imperial College London. The findings were published in the journal Aging Nature.
The test could be particularly valuable for individuals with a family history of Parkinson’s, genetic risk factors, or early non-motor symptoms such as REM sleep behavior disorder. It could also aid pharmaceutical companies in selecting candidates for clinical trials targeting early-stage disease.
Beyond diagnosis, the test may help track the effectiveness of treatments by monitoring RNA fragment levels over time, giving clinicians a powerful tool to personalize therapy.
With broader clinical trials underway, the test could soon be available in community clinics, making early Parkinson’s screening widely accessible for the first time.
European leaders backing Ukraine met in Berlin on Thursday 19 November and warned that no peace deal should be settled without them.
Three people have been killed and around 15 injured after Russian ballistic missiles struck three bridges over the Dnipro River in Kyiv, according to the Ukrainian capital’s mayor, Vitali Klitschko.
Azerbaijani President Ilham Aliyev met Vietnamese Prime Minister Le Minh Hung in Hanoi on 20 November, during a visit highlighting the longstanding friendship and growing strategic partnership between the two countries.
Britain and the European Union have reached an agreement to ease trade, expand opportunities for young people and deepen economic ties, in a major step towards rebuilding relations after Brexit.
Georgia has declared 22 November 2026 a national day of mourning following a deadly residential building collapse in the Kvemo Ponichala district of Tbilisi.
For the first time in more than a quarter of a century, the United States can no longer say it has eliminated measles as health experts warn the American outbreak reflects a collapse in trust in vaccines.
A new study in mice suggests the brain’s protective barrier does more than block harmful substances. It also delivers essential proteins from the body, a process that may break down early in Alzheimer’s disease and offer a new target for treatment.
Here's your AnewZ Daily Brief for the 5th of November, as health emergencies, humanitarian crises, political shifts, and cybersecurity threats put governments and essential services under pressure across the globe. Here are five stories worth your attention.
Kazakhstan plans to manufacture 494 types of medicines through eight major investment projects worth a combined $862 million, Health Minister Akmaral Alnazarova announced on 3 November, local media reported.
Dengue fever has killed more people in Bangladesh this year than in the whole of 2025, with October the deadliest month so far, data from Bangladesh's Health Ministry shows.
You can download the AnewZ application from Play Store and the App Store.
What is your opinion on this topic?
Leave the first comment